Results 181 to 190 of about 16,210 (241)

NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization

open access: yesJournal of Virology, 2021
Hepatitis B virus (HBV) infection is mediated by a specific interaction with sodium taurocholate-cotransporting polypeptide (NTCP), a viral entry receptor. Although the virus-receptor interactions are believed to trigger viral internalization into host cells, the exact molecular mechanisms of HBV internalization are not understood.
Kento Fukano   +2 more
exaly   +4 more sources

Clinical effects of NTCP‐inhibitor myrcludex B

Journal of Viral Hepatitis, 2021
AbstractWith extensive research on the pathogenesis and treatment of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, the current treatment of interferon and nucleoside or nucleotide analogues provides reasonable control of viral replication in chronic hepatitis B (CHB).
Dongliang Cheng   +3 more
openaire   +3 more sources

Structure of the bile acid transporter and HBV receptor NTCP

Nature, 2022
Chronic infection with hepatitis B virus (HBV) affects more than 290 million people worldwide, is a major cause of cirrhosis and hepatocellular carcinoma, and results in an estimated 820,000 deaths annually1,2. For HBV infection to be established, a molecular interaction is required between the large glycoproteins of the virus envelope (known as LHBs ...
Jinta Asami   +17 more
openaire   +3 more sources

NTCP opens the door for hepatitis B virus infection

Antiviral Research, 2015
A liver bile acids transporter, sodium taurocholate cotransporting polypeptide (NTCP, encoded by SLC10A1) was recently identified as a functional receptor for hepatitis B virus (HBV) and its satellite hepatitis D virus (HDV). NTCP-complemented human hepatoma HepG2 cells (HepG2-NTCP) were shown to support infection of HBV and HDV in vitro, providing a ...
Huan Yan, Jianhua Sui, Wenhui Li
exaly   +3 more sources

Role of sodium taurocholate cotransporting polypeptide (NTCP) in HBV-induced hepatitis: Opportunities for developing novel therapeutics.

Biochemical Pharmacology, 2023
Hepatitis B is an infectious disease caused by the HBV virus. It presents a significant challenge for treatment due to its chronic nature and the potential for developing severe complications, including hepatocirrhosis and hepatocellular carcinoma. These
Zhentao Zhang   +8 more
semanticscholar   +1 more source

Oligomerization of the HBV/HDV functional receptor NTCP expressed in Sf9 insect cell

Biochimica Et Biophysica Acta - General Subjects, 2022
BACKGROUND Sodium taurocholate co-transportering polypeptide (NTCP, SLC10A1) is a vital bile acid transporter and the functional receptor of hepatitis B and D virus.
Lushan Yu, Su Zeng
exaly   +2 more sources

Home - About - Disclaimer - Privacy